Bank of Nova Scotia’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,747
Closed -$235K 1124
2023
Q1
$235K Sell
3,747
-63
-2% -$3.93K ﹤0.01% 1036
2022
Q4
$239K Buy
+3,810
New +$218K ﹤0.01% 1080

Other funds holding PBH

Bank of Nova Scotia's PBH Position: Q2 2023 in Review

Bank of Nova Scotia sold out of Prestige Consumer Healthcare (PBH) in Q2 2023, closing a stake of 3,747 shares — an estimated $235K sold.

Bank of Nova Scotia first reported a position in PBH in Q4 2022 and held it in 2 quarters. The position peaked at $239K in Q4 2022. 279 funds tracked by Wall St. Rank hold PBH as of Q2 2023.

  • Bank of Nova Scotia reported no remaining Prestige Consumer Healthcare position as of Q2 2023 after selling out during the quarter.
  • Bank of Nova Scotia sold 3,747 Prestige Consumer Healthcare shares in Q2 2023, an estimated $235K.
  • Bank of Nova Scotia first reported a position in Prestige Consumer Healthcare in Q4 2022 and held it in 2 quarters.
  • Bank of Nova Scotia's Prestige Consumer Healthcare position peaked at $239K in Q4 2022.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2023.

Based on Bank of Nova Scotia's 13F filing for Q2 2023, filed 3 Aug 2023.